Canntab Therapeutics raised 3 million dollars and receives final Health Canada Licence

Canntab Therapeutics raised 3 million dollars and receives final Health Canada Licence

Canntab Therapeutics (CSE: PILL-OTCQB: CTABF) CFO Richard Goldstein joined Steve Darling from Proactive in Vancouver to discuss the major announcement from the company that they have received their key Heath Canada Licence that allows them Processing & Sales for Medical Purposes. Goldstein also discussed how much money they were able to raise and why a…